可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Strakova N, Ehrmann J, Bartos J, et al. Peroxisome proliferatoractivated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors[J]. Neoplasma, 2005, 52 (2): 126-136.
[2] Muzio G, Martinasso G, Trombetta A, et al. HMG-CoA reductase and PPARalpha are involved in clofibrateinduced apoptosis in human keratinocytes[J]. Apoptosis, 2006, 11 (2): 265-275.
[3] Kubota T, Yano T, Fujisaki K, et al. Fenofibrate induces apoptotic injury in cultured human hepatocytes by inhibiting phosphorylation of Akt[J]. Apoptosis, 2005, 10 (2): 349-358.
[4] Wang H, Nawata J, Kakudo N, et al. The upregulation of ICAM1 and Pselectin requires high blood pressure but not circulating reninangiotensin system in vivo[J]. J Hypertens, 2004, 22 (7): 1323-1332.
[5] Wencker D, Chandra M, Nguyen K, et al. A mechanistic role for cardiac myocyte apoptosis in heart failure[J]. J Clin Invest, 2003, 111 (10): 1497-1504.
[6] 吴强, 李隆贵, 蔡运昌, 等. 心衰大鼠心肌核因子κB活化及其与心肌细胞凋亡的关系[J]. 中国病理生理杂志, 2003, 19 (5): 649-652.
[7] Liang F, Wang F, Zhang S, et al. Peroxisome proliferator activated receptor (PPAR) alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes[J]. Endocrinology, 2003, 144(9): 4187-4194.